Advertisement
U.S. Markets closed

CARDIOFLOW-B (2160.HK)

HKSE - HKSE Delayed Price. Currency in HKD
0.750+0.020 (+2.74%)
At close: 04:08PM HKT

CARDIOFLOW-B

No. 1661 Zhangdong Road
Zhangjiang Hi-Tech Park Pudong New District
Shanghai 201203
China
86 21 3895 4600
https://www.cardioflowmedtech.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees483

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey R LindstromPresident, GM & Executive Director3.39MN/A1967
Mr. Liang ZhaoExecutive Director & First VP of Total Solutions1.9MN/A1980
Ms. Luying YanVP & Executive Director1.75MN/A1982
Ms. Xiangmei LiJoint Company SecretaryN/AN/AN/A
Ms. Lok Yee Chan A.C.I.S., A.C.S.Joint Company SecretaryN/AN/A1990
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super sti¬ff guidewire, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2010 and is headquartered in Shanghai, China.

Corporate Governance

CARDIOFLOW-B’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.